An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
21 Apr, 2020
Authors: Hill LF, Turner MA, Lutsar I, et al; NeoVanc Consortium.